IL2 and endometrial cancer: Likewise, the dysregulation of the IL2–STAT5 pathway, known for its role in T cell homeostasis and immune response, has been implicated in endometrial cancer and may reflect an imbalance in local or systemic immune tolerance in women with endometriosis [73].